What to Expect

What to Expect

Your Seattle Cancer Care Alliance (SCCA) doctors will consider clinical studies that might be appropriate for you as they develop your treatment plan. They will recommend treatment in a study if they believe it has the best potential to cure your disease, halt the progression, or help you in other ways. Some types of cancer, like breast cancer, have a number of studies available, while other diseases, such as head and neck cancers, have few.

Your experience in a study will depend on a number of factors, including the type of study, the phase of study, and the type and stage of your disease. Depending on the clinical study, you may be treated at any of the SCCA clinic locations or at one of our satellite or network sites.

Sometimes, participating in a clinical study is as simple as agreeing to let researchers have a copy of the results of a test you would have had anyway, such as a magnetic resonance imaging (MRI) scan. Other studies are more involved and may require more tests and visits to the clinic than a standard treatment regimen would.

People who enroll in clinical studies are not isolated in a laboratory or special research facility. If you decide to enroll in a study at SCCA, you will see the same doctors and nurses, and receive treatment in the same clinic, as if you were receiving the standard treatment for your disease.

You will receive the same high level of care at SCCA whether you are enrolled in a clinical study or not. Similarly, the quality of care will not vary if you choose one clinical study at SCCA over another.

Patient safety is extremely important to us at SCCA. We do everything we can to protect all our patients against unnecessary risks while in treatment, whether in a clinical study or not. State, national, and international regulations and policies protect the rights, safety, and well-being of people who are enrolled in clinical studies and ensure that studies are conducted according to strict scientific and ethical principles. Read more about safety of participants in clinical studies.